reporting data for period 1 - practice innovation …... cqm source reporting 5 (depending on...

17
www.evidencenowsw.org 1 Reporting Data for Period 1

Upload: others

Post on 11-Jul-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org 1

Reporting Data for Period 1

Page 2: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org

WEBINAR OBJECTIVES

2

1 ABCS MeasuresCQM Source Reporting - DQIP

ENSW REPORTING REQUIREMENTS

2Updated documentationUpdated DARTNet Reporting Options TableRolling Reporting TimelineUpdated Num-Denom Instructions

ENSW DATA REPORTING METHODS

3 DISCUSSION & QUESTIONS

4 CONTACT INFO

Method Breakdown 101

Page 3: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org

ENSW

REPORTING

REQUIREMENTS• ABCS Measures

• CQM Source Reporting – DQIP

• **Measure Specs on PIPCO site!

Page 4: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org

ENSW CLINICAL QUALITY MEASURES

4

Topic Description NQF PQRS

A: Aspirin

Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) in the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular disease (IVD) during the measurement period and who had documentation of use of aspirin or another antithrombotic during the measurement period

0068 204

B: Blood Pressure Management

Percentage of patients aged 18 through 85 years of age who had a diagnosis of hypertension (HTN) and whose blood pressure (BP) was adequately controlled (<140/90) during the measurement year.

0018 236

C: Cholesterol Management

Percentage of high-risk adult patients aged >= 21 years who were previously diagnosed with or currently have an active diagnosis of clinical atherosclerotic cardiovascular disease (ASCVD); OR adult patients aged >=21 years with a fasting or direct Low-Density Lipoprotein Cholesterol (LDL-C) level >= 190 mg/dL; OR patients aged 40-75 years with a diagnosis of diabetes with a fasting or direct LDL-C level of 70-189 mg/dL; who were prescribed or are already on statin medication therapy during the measurement year.

N/A N/A

S: Smoking Cessation Support

Percentage of patients aged 18 years or older who were screened about tobacco use one or more times within 24 months AND who received cessation counseling intervention if identified as a tobacco user.

0028 226

Page 5: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org

CQM SOURCE REPORTING

5

(Depending on practice determination found in Practice Survey/DQIP)

From CQM Report

Data SourceAspirin

(NQF 0068)

Blood pressure management (NQF 0018)

Cholesterol management

(New)

Smoking cessation support

(NQF 0028)

Patient-level data: Direct practice connection to DARTNet OR another organization who will capture data elements and calculate measures (e.g. HIE, NM PCA, etc.)

*Practice-level data: Numerators/Denominators from a non-EHR registry

*Practice-level data: Numerators/Denominators from EHR certified by ONC in 2014 or after

*Practice-level data: Numerators/Denominators from EHR certified by ONC prior to 2014

Patient-level data: Chart audit - using EHR data

Patient-level data: Chart audit - paper health record

*Practices that can only generate provider-level reports MUST 1) Create unique denominators and 2) Ensure that the same patient does not report for multiple providers in the practice.

Page 6: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org

CQM SPECIFICATIONS AVAILABLE

Cholesterol

• Measure Narrative

• N/D Flowchart

• Field Specifications

Smoking Cessation

• Measure Narrative

• N/D Flowchart

• Field Specifications

6

Aspirin

• Measure Narrative

• N/D Flowchart

• Field Specifications

Blood Pressure

• Measure Narrative

• N/D Flowchart

• Field Specifications

Page 7: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org

ENSW DATA

REPORTING

METHODS• Updated documentation

• Updated DARTNet Reporting

Options Table

• Rolling Reporting Timeline

• Updated Num-Denom

Instructions

Page 8: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org

REMEMBER RECEIVING THIS?

8

Page 9: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org

Page 12: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org 12

ROLLING REPORTING TIMELINE COHORT 1

ENSW Cohort 1 Rolling Reporting Timeline by Measurement Period

Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 Q3 2016 Q4 2016 Q1 2017

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar

BASELINE : (2015/01/01 - 2015/12/31)

Period 1 (Month 3): 2015/04/01 - 2016/03/31

Period 2 (Month 6): 2015/07/01 - 2016/06/30

Period 3 (Month 9): 2015/10/01 - 2016/09/30

OPTIONAL Period 4 (Month 12): 2016/01/01 - 2016/12/31

Period 5 (Month 15): 2016/04/01 - 2017/03/31

Page 13: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org

UPDATED NUMERATOR-DENOMINATOR INSTRUCTIONS

Page 14: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org

Discussion &

Questions• Method Breakdown 101

Page 15: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org

METHOD BREAKDOWN: 101

• Sending Patient-Level Data via

o Direct connection to DARTNet means:

Practice or another organization will send DI flat files

for Baseline and Periods 1-3, 5 (Period 4 optional)

Use ENSW Set Up Guide

Use Set Up Guide Table Layout

o Chart Audit means:

For paper charts, contact Maggie Dunham

15

How do I do this though, really…?

Page 16: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org

METHOD BREAKDOWN: 101

• Sending Practice-Level Data (Num/Denom) via:

o Non-EHR Registry:

Use practice’s preferred format

Or follow UPDATED Num-Denom Instructions

o EHR certified before/in/after 2014:

Contact EHR Vendor

16

How do I do this though, really…?

Page 17: Reporting Data for Period 1 - Practice Innovation …... CQM SOURCE REPORTING 5 (Depending on practice determination found in Practice Survey/DQIP) From CQM Report Data Source Aspirin

www.evidencenowsw.org 17

12631 E. 17th AvenueAurora, CO [email protected]

MAGGIE DUNHAMHIT Program Manager

THANK YOUQUESTIONS?

12635 E. Montview Blvd, Suite 136Aurora, CO [email protected]

Practice Performance Registry